Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Risk factors and alpha fetoprotein in diagnostics of hepatocelular carcinoma (CROSBI ID 614700)

Prilog sa skupa u zborniku | sažetak izlaganja sa skupa | međunarodna recenzija

Bago, Josip ; Babić, Žarko Risk factors and alpha fetoprotein in diagnostics of hepatocelular carcinoma // First international conference on hepatobiliary tumors, Milano 1992. Milano, 1992

Podaci o odgovornosti

Bago, Josip ; Babić, Žarko

engleski

Risk factors and alpha fetoprotein in diagnostics of hepatocelular carcinoma

In eight year period the 525 liver cirrhosis undergone autopsies, and 40 patients with hepatocelular cardinoma was diagnosed. In 40 patients with hepatocelular carcinoma, HBsAg was obtained in 11(27, 5%) patients, and antiHBc in 36% of patients. Alfafetoptorein eas positive in 75% of patients with liver tumor. From all data, it could be concluded that poersistant infection of B virus hepatitis could be signoficant i hepatocelular carcinoma ethiology, but liver cirrhosis and male sex, as risk factors, should be considered too.

alfafetopritein; liver tumours; risk factors

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

1992.

objavljeno

Podaci o matičnoj publikaciji

First international conference on hepatobiliary tumors, Milano 1992

Milano:

Podaci o skupu

First international conference on hepatobiliary tumors, Milano 1992

poster

30.08.1992-02.09.1992

Milano, Italija

Povezanost rada

Kliničke medicinske znanosti